You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR FACTOR XIII CONCENTRATE (HUMAN)


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for factor xiii concentrate (human)

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000717 ↗ The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS Completed National Institute of Allergy and Infectious Diseases (NIAID) N/A 1969-12-31 To determine the safety and effectiveness of clindamycin and primaquine in the treatment of mild Pneumocystis carinii pneumonia (PCP) in AIDS patients. As many as 80 percent of AIDS patients experience at least one episode of PCP and about one-third of these patients have a recurrence of the disease. Drugs currently used for treatment of acute PCP are toxic to the majority of AIDS patients. The combination of clindamycin and primaquine reduces the numbers of PCP organisms in laboratory tests and in animal studies. Both drugs can be given orally, concentrate in lung tissue, and have been used safely in humans for treatment of other diseases. It is possible that the combination may prove to be as good or better than standard therapy for PCP and side effects may be less.
NCT00002386 ↗ Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia Completed Merck Sharp & Dohme Corp. Phase 4 1969-12-31 The purpose of this study is to see if indinavir plus two other anti-HIV drugs affect blood clotting in HIV-positive patients with hemophilia.
NCT00004667 ↗ Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease Completed University of North Carolina Phase 1 1993-10-01 OBJECTIVES: I. Evaluate the effect of a new von Willebrand factor concentrate on bleeding time, in vivo recovery, and circulating half-life of the infused factor in patients with von Willebrand's disease. II. Assess the safety of von Willebrand factor in these patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for factor xiii concentrate (human)

Condition Name

Condition Name for factor xiii concentrate (human)
Intervention Trials
Hemophilia A 11
Bleeding 10
Trauma 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for factor xiii concentrate (human)
Intervention Trials
Hemorrhage 41
Hemophilia A 24
Hemostatic Disorders 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for factor xiii concentrate (human)

Trials by Country

Trials by Country for factor xiii concentrate (human)
Location Trials
United States 229
Canada 30
Italy 22
China 16
India 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for factor xiii concentrate (human)
Location Trials
California 18
New York 17
Pennsylvania 17
Georgia 17
Texas 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for factor xiii concentrate (human)

Clinical Trial Phase

Clinical Trial Phase for factor xiii concentrate (human)
Clinical Trial Phase Trials
Phase 4 51
Phase 3 52
Phase 2/Phase 3 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for factor xiii concentrate (human)
Clinical Trial Phase Trials
Completed 139
Recruiting 36
Terminated 21
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for factor xiii concentrate (human)

Sponsor Name

Sponsor Name for factor xiii concentrate (human)
Sponsor Trials
CSL Behring 20
Emory University 7
National Institute of Mental Health (NIMH) 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for factor xiii concentrate (human)
Sponsor Trials
Other 348
Industry 116
NIH 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.